Compound 769
Identifiers
- Canonical SMILES:
F[C@H]1CN(Cc2ccccc2-c2ccc(Cl)cc2)CC[C@@H]1N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F
- InChi:
InChI=1S/C46H50ClF4N7O5S3/c47-34-12-10-32(11-13-34)38-9-5-4-6-33(38)27-57-20-18-43(40(48)28-57)58-21-17-39-42(29-58)52-31-53-45(39)55-66(61,62)37-14-15-41(44(26-37)65(59,60)46(49,50)51)54-35(16-19-56-22-24-63-25-23-56)30-64-36-7-2-1-3-8-36/h1-15,26,31,35,40,43,54H,16-25,27-30H2,(H,52,53,55)/t35-,40+,43+/m1/s1
- InChiKey:
UKQHIIBGRGLONR-PGSJWCLOSA-N
External links
168318080 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 65 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.74 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 987.27 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.74 | |||
TPSA | 137.07 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 65 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 6.74 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5156 | Navitoclax | DB12340 | |
0.4191 | GDC-0349 | DB13072 | |
0.3833 | Quinupristin | DB01369 | |
0.3738 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3679 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3654 | Sulfaisodimidine | DB13283 | |
0.3639 | Presatovir | DB12165 | |
0.3631 | Omidenepag isopropyl | DB15071 | |
0.3608 | Bleomycin | DB00290 | |
0.3583 | Sparsentan | DB12548 | |
0.3574 | CH-5132799 | DB13051 | |
0.3531 | Elobixibat | DB12486 | |
0.3522 | Rivipansel | DB12778 | |
0.3484 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3477 | Gemigliptin | DB12412 |